与国家能力框架对比沙特阿拉伯本科药学课程的映射:两个PharmD课程的案例研究
Salihah Alfaifi1, Stephanie Bridges2, Naoko Arakawa2
1School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom; College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia.
Currents in pharmacy teaching & learning
|January 15, 2026
概括
沙特的PharmD计划部分与国家能力保持一致,强调技术技能而不是管理和公共卫生. 课程需要更新,以便更好地为不断变化的药房角色做好毕业生准备.
科学领域:
- 制药教育 制药教育
- 课程开发 课程开发
- 健康 专业 教育 卫生 专业 教育
背景情况:
- 在沙特阿拉伯,药学教育迅速扩大,转向药学博士 (PharmD) 学位.
- 制定国家能力框架,以指导课程改革,提高药剂师的准备能力.
- 观察到现有药学博士课程与国家能力框架的调整的变化.
研究的目的:
- 评估两个本科 PharmD 课程与拟议的基础级药剂师国家能力框架的协调性.
- 与国家药房实践标准相比,确定课程内容和结构的优点和弱点.
主要方法:
- 利用课程映射来分析两个PharmD课程的预期课程内容 (课程描述,学习成果).
- 采用定性内容分析来比较程序内容与国家能力框架中的行为陈述.
- 可视化能力覆盖,学科领域权重,并使用热图,雷达图表和描述性统计数据强调课程.
主要成果:
- 两个PharmD课程都展示了大多数建议能力的覆盖范围,更强调技术技能 (例如药物信息,化合物,通信).
- 确定了组织管理和公共卫生能力的不足,以及领导力,持续专业发展和患者咨询方面的差距.
- 两项课程之间在课程结构和内容上发现了显著的差异,与传统的药学学士模式差异化有限.
结论:
- 该研究提供了一种可重复的方法来评估药学课程与国家能力标准的一致性.
- 调查结果强调需要更平衡,基于能力的课程,以充分准备药学毕业生应对扩大角色和国家医疗保健需求.
- 建议修改 PharmD 课程,以更好地整合未来药房实践的基本能力.
更多相关视频
07:42Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition
Published on: September 3, 2016
15.5K
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.3K
相关概念视频
01:28Dosage Regimens: Designs and Approaches
266
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
266
01:28Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
155
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
155
01:28Biopharmaceutics and Pharmacokinetics: Overview
3.4K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.4K
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:23Dosage Regimen Designs: Nomograms and Tabulations
181
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
181